Loading…

Antibacterial and cytotoxic assessment of poly (methyl methacrylate) based hybrid nanocomposites

Poly (methyl methacrylate) (PMMA) is an extensively used implant material in biomedical devices. Biofilm formation creates issues in PMMA-based biomedical implants, while emergence of drug resistant pathogens poses an additional complication. Hence development of surfaces that resist bacterial colon...

Full description

Saved in:
Bibliographic Details
Published in:Materials Science & Engineering C 2019-07, Vol.100, p.886-896
Main Authors: Sathya, S., Murthy, P. Sriyutha, Devi, V. Gayathri, Das, Arindam, Anandkumar, B., Sathyaseelan, V.S., Doble, M., Venugopalan, V.P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Poly (methyl methacrylate) (PMMA) is an extensively used implant material in biomedical devices. Biofilm formation creates issues in PMMA-based biomedical implants, while emergence of drug resistant pathogens poses an additional complication. Hence development of surfaces that resist bacterial colonisation is extremely desirable. In this context, nanomaterials are among the potential choices. In the present work, nanocomposites (NCs) were developed by incorporation of chemically synthesized nanoparticles of CuO, cetyl trimethyl ammonium bromide (CTAB) capped CuO and ZnO (singly and in combination) in PMMA. The efficacy of these NCs was assessed against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) bacteria which are prevalent in many implant-associated infections. Results revealed species-specific response of the bacteria towards nanomaterials. CuO NC (0.1% (w/v)) was more effective against E. coli, while CTAB capped CuO NC and ZnO NC were very effective against S. aureus. Furthermore, combination of nanoparticles improved efficacy of nanocomposites against both the bacterial species. In vitro cytotoxicity assay using L6 myoblast cell line showed that all NCs at 0.1% (w/v) were biocompatible, showing >85% cell viability. The present study suggests that combination of NPs is a promising option to combat implant infection by multiple organisms. [Display omitted] •PMMA based nanocomposites of CuO, CTAB capped CuO and ZnO were prepared.•They showed differential activity against Gram positive and Gram negative bacteria.•Hybrid nanocomposites showed better antibacterial effect against both types of species.•Nanocomposites acted by damaging the cell membrane of the bacteria.•All nanocomposites exhibited biocompatibility towards L6 myoblast cell line at 0.1% (w/v).
ISSN:0928-4931
1873-0191
DOI:10.1016/j.msec.2019.03.053